首页> 外文OA文献 >Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

【2h】

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

机译：Checkpoint抑制剂通过增强慢病毒载体诱导的肿瘤特异性免疫和佐剂介导的抗肿瘤功效，与治疗平台ZVex™和GLAAS™协同作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Checkpoint inhibitors synergize with therapeutic platforms, ZVex? and GLAAS? by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy [J] . Tina C Albershardt, Andrea J Parsons, Jan ter Meulen, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：检查点抑制剂与治疗平台ZVex协同作用？和GLAAS？通过增强慢病毒载体诱导的肿瘤特异性免疫和佐剂介导的抗肿瘤功效
2. Enhancing the therapeutic efficacy of immune checkpoint inhibition and targeted therapy using anti-tumor antibodies in mouse melanoma [J] . Perez-Lorenzo R., Erjavec S., Clynes R., The Journal of investigative dermatology. . 2018,第5a19期

机译：使用小鼠黑素瘤中的抗肿瘤抗体增强免疫检查点抑制和靶向治疗的治疗效果
3. Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy [J] . Kulkarni Ashish, Natarajan Siva Kumar, Chandrasekar Vineethkrishna, ACS nano . 2016,第10期

机译：结合免疫检查点抑制剂和抑制激酶的超分子疗法来增强抗癌功效
4. Microtubule-Depolymerizing Agents Used in ADCs Induce Anti-Tumor Immunity and Synergize with Immune Checkpoint Blocking Antibodies [C] . Philipp Muller, Kea Martin, Sebastian Theurich, PEGS . 2014

机译：ADCS中使用的微管 - 解聚剂诱导抗肿瘤免疫，并用免疫检查点阻断抗体进行协同
5. Understanding How Adrenergic Stress Signaling Impacts the Anti-Tumor Immune Response and the Efficacy of Checkpoint Inhibitors in Murine Tumor Models [D] . Bucsek, Mark Joseph. 2019

机译：了解肾上腺素能应激信号如何影响抗肿瘤免疫应答以及检查点抑制剂在鼠肿瘤模型中的疗效
6. Checkpoint inhibitors synergize with therapeutic platforms ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy [O] . Tina C Albershardt, Andrea J Parsons, Jan ter Meulen, 2015

机译：Checkpoint抑制剂通过增强慢病毒载体诱导的肿瘤特异性免疫和佐剂介导的抗肿瘤功效与治疗平台ZVex™和GLAAS™协同作用
7. The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma [O] . Nabil Amirouchene-Angelozzi, Estelle Frisch-Dit-Leitz, Guillaume Carita, 2016

机译：MTOR抑制剂everolimus与PI3K抑制剂GDC0941协同增强，以增强UVEAL黑色素瘤的抗肿瘤疗效

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

著录项

引文网络

相似文献

相关主题

期刊订阅